|
⚲
|
| Keyboard |
| Garner Thomas
✚
|
|
|---|---|
| CIK # | 0001996325 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001996325] | |
| 4 | [0001996325] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Garner Thomas | |
| Acadia Pharmaceuticals Inc | |
| Lexicon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acadia Pharmaceuticals Inc ACAD
Stock Option (Right to Buy) · derivative
|
2026-03-06 | Grant | 97,947 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 28,493 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-12-09 | Grant | 45,372 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Stock Option (Right to Buy) · derivative
|
2024-12-09 | Grant | 235,849 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2024-02-08 | Grant | 227,130 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2024-02-08 | Grant | 227,130 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2023-10-09 | Grant | 248,923 | $0.00 |